George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 115.00
Ask: 117.00
Change: -2.50 (-2.13%)
Spread: 2.00 (1.739%)
Open: 120.50
High: 120.50
Low: 115.00
Prev. Close: 117.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Apr 2022 14:35

RNS Number : 1590I
Bakkavor Group PLC
12 April 2022
 

Bakkavor Group plc

Transaction by PDMR

12 April 2022

 

Bakkavor Group plc

(the 'Company' or 'Bakkavor')

Vesting of conditional awards under the Bakkavor Group plc Long Term Incentive Plan ("LTIP") / Notification and public disclosure of transaction by PDMR

Bakkavor Group plc (LON: BAKK) announces that on 9 April 2022 the Company's Chief Financial Officer, Ben Waldron, acquired 53,522 ordinary shares of 2 pence each in the Company for nil consideration upon the vesting of an award granted under the Company's LTIP in April 2019.

The award was settled with existing shares sourced from the Company's employee benefit trust.

Mr Waldron elected to settle the income tax and NIC liability due in connection with the settlement of the award with personal funds and accordingly retained the full number of shares vesting to him under the award.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Waldron

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bakkavor Group plc

b)

LEI

213800COL7AD54YU9949

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2 pence each in Bakkavor Group plc

GB00BF8J3Z99

b)

Nature of the transaction

Settlement of a conditional award under the Company LTIP that vested on 9 April 2022 in respect of 53,522 ordinary shares.

Existing shares acquired for nil consideration.

No related sales for tax liability.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil

 53,522

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

9 April 2022

f)

Place of the transaction

Outside a trading venue

 

 

 -Ends-

Enquiries

Company Secretarial:

Annabel Tagoe-Bannerman, Group General Counsel and Company Secretary +44 (0) 20 7908 6130

 

Institutional investors and analysts:

Emily Daw, Head of Investor Relations +44 (0) 20 7908 6114

About Bakkavor 

Bakkavor is the leading provider of fresh prepared food ("FPF") in the UK, with a growing international presence in the US and China. The Group is the number one by market share in the UK in the four FPF product categories of meals, salads, desserts and pizza & bread, providing high-quality, fresh, healthy and convenient food. Its customers include every major UK grocery retailer, including Tesco, Marks & Spencer, Sainsbury's and Waitrose, and some of the world's best-known food brands. Bakkavor was founded in 1986 and has its headquarters in London. The Group has c.19,000 employees and operates 23 factories in the UK, 5 in the US and 9 in China.

 

LEI number: 213800COL7AD54YU9949

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVVSFIFLIF
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.